Statin Drug May Slow Alzheimer's

Published Online: Thursday, September 1, 2005

Preliminary research suggests that the cholesterol-lowering drug atorvastatin (Lipitor) may help boost thinking ability and control psychiatric symptoms in patients with mild-to-moderate Alzheimer's disease (AD). The study included 67 AD patients who received either atorvastatin or placebo. The patients were evaluated using standard measures of cognitive function, psychiatric symptoms, and the ability to navigate common activities of daily living. They were also tested for changes in blood cholesterol levels. The study, which was conducted at the Sun Health Research Institute in Sun City, Ariz, revealed that "daily administration of 80 mg of atorvastatin calcium significantly reduces circulating cholesterol levels and may have a positive effect on the progressive deterioration of cognitive function and behavior anticipated in mild-to-moderate AD," the researchers said. Two larger, multicenter trials are currently under way to further investigate the possible benefits of atorvastatin treatment in patients with AD.

Latest Articles
Bryan Ziegler, PharmD, executive director of Kennedy Pharmacy Innovation Center, provides some resources for community pharmacists to use when implementing new collaborative services with primary care providers.
James Schiffer, RPh, associate at Allegaert Berger & Vogel LLC, discusses some tips for pharmacists who are facing a Drug Enforcement Administration audit.
Carlos Aquino, founder and president of PharmaDiversion LLC, talks about the importance of the Drug Enforcement Administration's (DEA) diversion website.
Having trouble getting your hands on FluMist?
Latest Issues